Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Subacute sclerosing panencephalitis

Infectious and Parasitic Diseases

Subacute sclerosing panencephalitis is a rare form of progressive brain inflammation caused by a persistent infection with a mutated wild type strain of the measles virus, arising years after a person has apparently recovered normally from the original measles infection rather than from any vaccine strain. Symptoms typically appear about ten years after the initial infection, though the interval can range from one month to 27 years, and the disease progresses through four stages marked by behavioral changes, seizures, vision loss, coordination problems and eventual loss of consciousness. Following the onset of the second stage the disease is invariably fatal, with death typically occurring within months to years and spontaneous remission occurring in only about five percent of cases. About two in 10,000 measles cases develop the condition, with unvaccinated infants under 15 months facing a substantially higher risk of roughly one in 609.

Facts
Classification
Body System
Nervous System 1
ICD-10 Chapter
I: Certain Infectious and Parasitic Diseases 2
Communicable or Non-communicable
Communicable 3
Causative Agent
Causative Agent (category)
Viral 1
Sources
1. Subacute sclerosing panencephalitis (Wikipedia)
lead sentence 1
Quote, lead sentence 1
Subacute sclerosing panencephalitis (SSPE), also known as Dawson disease, is a rare form of progressive brain inflammation caused by a persistent infection with the measles virus.
View the Source
2. Wikidata: Subacute sclerosing panencephalitis
Wikidata P494 (A81.1)View the Source
3. National Library of Medicine: MeSH Descriptor Data: Subacute Sclerosing Panencephalitis
National Library of MedicineMeSH tree number C01.207.245.340.600
Quote, MeSH tree number C01.207.245.340.600
A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS .
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.